-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright
-
-
-
-
-
-
-
FDA accepts GSK's bepirovirsen for priority review in hepatitis B treatment
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $104 at Oppenheimer
-
-
-
-
-
-
-
BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS): New positive donidalorsen data to be presented at AAAAI/WAO
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
-
-
-
-
-
-
-
Ionis shares significant business and pipeline progress at Innovation Day, highlighting strength of capabilities from research and technology through commercialization
-
15,747 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

